Azerbaijani
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Pakistan Journal of Pharmaceutical Sciences 2012-Jan

Role of herpes simplex virus-1, cytomegalovirus and Epstein-Barr virus in atherosclerosis.

Yalnız qeydiyyatdan keçmiş istifadəçilər məqalələri tərcümə edə bilərlər
Giriş / Qeydiyyatdan keçin
Bağlantı panoya saxlanılır
Abdullah Al-Ghamdi

Açar sözlər

Mücərrəd

Infectious agents such as herpes viruses may be implicated in the inflammatory atherosclerotic process. The aim of this study was to assess the levels of IgG antibody specific for Herpes simplex virus-1 (HSV-1), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) among patients with atherosclerotic vascular diseases and to examine the relation between the levels of these antibodies and lipid profile, high-sensitive C-reactive protein (hsCRP) in these patients. Seventy five patients [20 with acute coronary artery disease (ACAD), 20 with chronic coronary artery disease (CCAD), 20 with cerebral stroke and 15 with peripheral arterial disease (PAD)] along with 15 healthy individuals as a control group. The studied individuals were subjected to complete history taking, thorough physical examination, and assessment of the blood glucose level, lipid profile, creatine kinase (CK), hsCRP by nephlemetry and virus-specific IgG antibodies by enzyme immunoassay (EIA). Results showed that the levels of cholesterol, triglycerides, LDL-c and hsCRP were significantly higher, while HDL-c was significantly lower among patients compared to that of the controls. A significantly (p<0.05) higher percentage of patients had CMV-specific IgG as compared to the controls. Higher percentage of patients had HSV- and EBV-specific IgG antibodies, however, there was no significant difference between the 2 groups. Individuals who had CMV-specific IgG were more liable to have vascular disease compared to those without (OR=4.10, CI= 1.07-15.75). The levels of CMV- and EBV-specific IgG antibodies were significantly (P<0.01 and < 0.05 respectively) elevated among patients with atherosclerotic vascular diseases when compared to those of the controls. There was no significant correlation between the levels of virus-specific IgG and lipid profile or hsCRP. In conclusion, the level of CMV- and EBV- specific antibodies are elevated among vascular disease patients and the presence of CMV-specific IgG is associated with development of the disease. Serum lipids and hsCRP were increased among the studied patients; however, no significant correlation was detected between antiviral IgG levels and lipid profile or hsCRP.

Facebook səhifəmizə qoşulun

Elm tərəfindən dəstəklənən ən tam dərman bitkiləri bazası

  • 55 dildə işləyir
  • Elm tərəfindən dəstəklənən bitki mənşəli müalicələr
  • Təsvirə görə otların tanınması
  • İnteraktiv GPS xəritəsi - yerdəki otları etiketləyin (tezliklə)
  • Axtarışınızla əlaqəli elmi nəşrləri oxuyun
  • Təsirlərinə görə dərman bitkilərini axtarın
  • Maraqlarınızı təşkil edin və xəbər araşdırmaları, klinik sınaqlar və patentlər barədə məlumatlı olun

Bir simptom və ya bir xəstəlik yazın və kömək edə biləcək otlar haqqında oxuyun, bir ot yazın və istifadə olunan xəstəliklərə və simptomlara baxın.
* Bütün məlumatlar dərc olunmuş elmi araşdırmalara əsaslanır

Google Play badgeApp Store badge